Article
CD155/PVR as a determinant of anti-HER2 therapy sensitivity in breast cancer
2025-11-14
Abstract excerpt
<title>Abstract</title> <p> CD155 (poliovirus receptor, PVR) is frequently overexpressed across cancers and has been associated with tumor progression, poor prognosis, and therapy resistance. Here, we identify CD155 as a modulator of HER2-targeted monoclonal antibody efficacy. Analysis of clinical datasets revealed that high CD155 expression correlates with overall, progression-free, and disease-specific surviva...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 48ec52a6-580c-587f-95d8-9ff3a2413a01
- DOI
- 10.21203/rs.3.rs-7994408/v1
